These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2498296)

  • 1. Valproic acid, unlike other anticonvulsants, has no effect on methadone metabolism: two cases.
    Saxon AJ; Whittaker S; Hawker CS
    J Clin Psychiatry; 1989 Jun; 50(6):228-9. PubMed ID: 2498296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anticonvulsants.
    Wilbur R; Kulik FA
    Am J Hosp Pharm; 1981 Aug; 38(8):1138-43. PubMed ID: 6791497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of propoxyphene napsylate and methadone in the treatment of opiate dependence.
    Wang RI; Kochar C; Hasegawa AT; Roh BL
    NIDA Res Monogr; 1982 Apr; 41():253-60. PubMed ID: 6126814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow tapering from methadone maintenance in a program encouraging indefinite maintenance.
    Calsyn DA; Malcy JA; Saxon AJ
    J Subst Abuse Treat; 2006 Mar; 30(2):159-63. PubMed ID: 16490679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report of barbiturate-induced enhancement of methadone metabolism and withdrawal syndrome.
    Liu SJ; Wang RI
    Am J Psychiatry; 1984 Oct; 141(10):1287-8. PubMed ID: 6486271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone withdrawal psychosis.
    Levinson I; Galynker II; Rosenthal RN
    J Clin Psychiatry; 1995 Feb; 56(2):73-6. PubMed ID: 7852256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of symptom complaints in methadone maintenance patients.
    Dyer KR; White JM
    Addiction; 1997 Nov; 92(11):1445-55. PubMed ID: 9519488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium valproate in the treatment of the alcohol withdrawal syndrome.
    Lambie DG; Johnson RH; Vijayasenan ME; Whiteside EA
    Aust N Z J Psychiatry; 1980 Sep; 14(3):213-5. PubMed ID: 6783023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug interactions of methadone with CNS-active agents].
    Moreno Brea MR; Rojas Corrales O; Gibert-Rahola J; Micó JA
    Actas Esp Psiquiatr; 1999; 27(2):103-10. PubMed ID: 10380152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences.
    Krabbe PF; Koning JP; Heinen N; Laheij RJ; van Cauter RM; De Jong CA
    Addict Biol; 2003 Sep; 8(3):351-8. PubMed ID: 13129838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of propoxyphene napsylate in the treatment of heroin and methadone addiction.
    Inaba DS; Gay GR; Whitehead CA; Newmeyer JA; Bergin D
    West J Med; 1974 Aug; 121(2):106-11. PubMed ID: 4847425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratio.
    Bell J; Shearer J; Ryan A; Graham R; Korompay K; Rizzo S; Sindhusake D; Somogyi AA
    Exp Clin Psychopharmacol; 2009 Jun; 17(3):146-53. PubMed ID: 19586229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case report on methadone withdrawal syndrome].
    Chuang P
    Hu Li Za Zhi; 2009 Dec; 56(6):95-100. PubMed ID: 19953462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluctuations in (R,S)-methadone pharmacokinetics and response among long-term methadone maintenance patients.
    Mitchell TB; Dyer KR; Newcombe D; Somogyi AA; White JM
    Addict Biol; 2006 Jun; 11(2):170-4. PubMed ID: 16800831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.